Grow Your Business Beyond Borders
International trade solutions for businesses of all sizes and industries
About Pannexus
Our Expertise
At Pannexus, we specialize in connecting businesses with international trade opportunities within the sectors of retail and government. Our team of experts has a wealth of knowledge in sourcing deals in the British and European landscape, to bring these to the USA. We have knowledge of regulatory pathways, compliance, legal services, experience in market entry to major retail businesses and government contracts in the USA.
Our Approach
We take a personalized approach to every client we work with, ensuring that we understand their unique needs and goals. Our team works closely with our clients to source and conduct due diligence on relevant products, develop customized solutions that ensure successful cross-border transactions. We work across various industries including healthcare, technology, nutraceuticals, skin care, cosmetics, devices and energy.
Our Network
We have a vast network of international partners and contacts in the UK, Europe and the USA that we leverage to help our clients expand their reach. Through our network, we can help businesses in UK, Europe and USA find new markets with a focus on entering the USA, identify potential buyers/suppliers within the USA retail sector, USA Government and Department of Defence.
About US
Dr Laila Samady-Mustad, Partner
Dr Laila Samady-Mustad, Partner
Dr Laila Samady-Mustad, Partner
Laila Samady-Mustad is a scientist, advisor, entrepreneur and investor with more than 25 years’ experience in the pharmaceutical, medical and biotechnology industry in the UK, US and France. Her expertise is in medical affairs, partnerships, business development and capital raising strategies.
Based in London, she is a Venture Partner, Ad
Laila Samady-Mustad is a scientist, advisor, entrepreneur and investor with more than 25 years’ experience in the pharmaceutical, medical and biotechnology industry in the UK, US and France. Her expertise is in medical affairs, partnerships, business development and capital raising strategies.
Based in London, she is a Venture Partner, Advisor and Member of the Investment Committee at Ryse Asset Management, a Health Technology investment firm. She serves on the Board / Advisory / C-suite of several medical technology and biotechnology companies, including Curio Digital Therapeutics in mental health, Covanos Inc, in cardiovascular diagnostics and companies in the sector of longevity and healthy lifespan. She is a Founder and Director at Pannexus Ltd, a consultancy firm specialising in business development, marketing and international trade opportunities for companies in Europe and US, within the sectors of retail and government.
Previously, she held senior executive positions, scientific and business development roles, in several early-stage medical technology companies in the USA. While at Boehringer Ingelheim, she served in increasingly senior roles in Washington DC and London, leading to Global Partnerships in Oncology.
Laila holds a PhD in Molecular Pathology and Immunology from University College London and her work led to a spin-out company, BioVex, which was acquired by Amgen for $1Bn. This started the field of Oncolytic Viruses (a form of immunotherapy for cancer).
Prior to her PhD, Laila obtained an MSc in Molecular and Cell Biology from Institut Pasteur and a BSc in Biochemistry from Trinity College, Hartford, CT, USA.
Eduardo Mustad, Partner
Dr Laila Samady-Mustad, Partner
Dr Laila Samady-Mustad, Partner
Eduardo Mustad joined the Mustad United Group in 2012 as an administrator where he serves on the board of five companies. The Mustad Group was founded in 1832 in Norway and Eduardo is the seventh generation Mustad involved in the company.
He is a Founder and Director of Interselect NV since 2005, a firm advising equity funds that invests
Eduardo Mustad joined the Mustad United Group in 2012 as an administrator where he serves on the board of five companies. The Mustad Group was founded in 1832 in Norway and Eduardo is the seventh generation Mustad involved in the company.
He is a Founder and Director of Interselect NV since 2005, a firm advising equity funds that invests in stock markets around the world.
Prior to this, Eduardo was involved in the initial process of setting up Albert Inc. a startup company specialising in knowledge management, as well as providing competitive intelligence research to them.
He began his career in Germany and in the US with REHAU, a tier one supplier to car companies, working in various engineering roles.
Eduardo has a BSc in Mechanical Engineering from Trinity College in Hartford, Connecticut, and an MBA from Cranfield School of Management.
Eduardo has lived in six countries across three continents, America, Europe and Asia.
Dr. Klaus O. Schafer, Strategic Advisor
Dr. Klaus O. Schafer, Strategic Advisor
Dr. Klaus O. Schafer, Strategic Advisor
Brigadier General (Ret.) Klaus O. Schafer, MD, MPH, MSc has over 35+ years of leadership experience in government and industry. He currently serves on the board of Altimmune Inc. (NASDAQ-ALT), a late-stage clinical biopharmaceutical company, developing therapies for serious liver diseases. He has been an independent consultant since 20
Brigadier General (Ret.) Klaus O. Schafer, MD, MPH, MSc has over 35+ years of leadership experience in government and industry. He currently serves on the board of Altimmune Inc. (NASDAQ-ALT), a late-stage clinical biopharmaceutical company, developing therapies for serious liver diseases. He has been an independent consultant since 2002 and has served as advisory board member to several biotech and health related companies.
As a physician, his military medical career spanned all aspects of leading and managing the U.S. Air Force integrated health care system, including direct patient care, policy development, quality oversight and budgeting of clinics, hospitals and the entire U.S. Air Force medical system. As US Air Force Assistant Surgeon General for Medical Readiness, Science and Technology, he was responsible for the transformation of all military medical forward deployed clinical teams, their training and adoption of all deployed medical equipment and the policy oversight of military air evacuation. His transformational efforts set the stage for a 98% wounded soldier survival rate through initial field stabilization and prompt air transport to a tertiary care hospital for definitive care. He introduced numerous advanced technologies into medical practice for deployed units none of which were available in the private sector at the time.
Upon retirement he became public health advisor to the Defense Threat Reduction Agency’s Advanced Strategic Concepts Office but was quickly moved to Acting Deputy Secretary of Defense (War) for Nuclear, Biologic and Chemical (NBC) Defense where he was responsible for the budget expansion from $1 billion to $2 billion for biological science and technology development within DoD. He developed policy, direction and budgeting for biothreat drug, vaccine and diagnostic device development, biosurveillance, personal protective equipment development, and training. His efforts led to the exploration of new advances and research in diagnostics, public health surveillance, drug and vaccine development.
After government he became CEO and co-founder of TessArae LLC, a startup biotech medical diagnostic device company which secured DoD microarray diagnostic technology for commercialization. He later held the position of chief medical officer and client executive for health at CACI International, a national security company heavily involved in delivering contracts to multiple government agencies.
Robert A. Heggie, Partner
Dr. Klaus O. Schafer, Strategic Advisor
Dr. Klaus O. Schafer, Strategic Advisor
Robert Heggie was reared in British Columbia, Canada, where he studied Psychology and English on a full scholarship for bagpipes at Simon Fraser University. He completed his studies at the British Columbia Institute of Technology, (BCIT) becoming a Certified Engineering Technician with an emphasis in civil & structural engineering. His
Robert Heggie was reared in British Columbia, Canada, where he studied Psychology and English on a full scholarship for bagpipes at Simon Fraser University. He completed his studies at the British Columbia Institute of Technology, (BCIT) becoming a Certified Engineering Technician with an emphasis in civil & structural engineering. His early career evolved into property management with responsibility for over 2,000,000 square feet of government buildings for one of British Columbia's largest building companies.
However, Robert found his true profession, retailing, when recruited to the Hudson Bay Company. During his decade there his senior executive roles included Operations, Financial Services and Licensing, and was classified as an “Insider” and member of the Management Committee. His specialty was the development of "licensed departments", or "store in store programs". This included leased space for independent retailers, branded products, franchises and unique market promotions for company stores / brands. He was instrumental in launching/expanding MAC Cosmetics at Hudson’s Bay when they were virtually unknown. He grew his portfolio into the most profitable division of the Company, generating over 30% of total company profits from less than 10% of the total selling area.
Using the skills and experiences gained to that point, Robert left Canada and founded HK Retail Concepts / Non-Traditional Retail, Inc. (NTR) consulting companies focused on third party programs with major retailers.
Now an internationally recognized leader in its niche, NTR projects include franchising, licensing, consulting, business and marketing plans, branding, including new concepts & products. NTR also negotiates agreements with and for major retailers, manufacturers and clients desiring introductions to major retailers. NTR helps create differentiation for retailers; managing and implementing store specific programs; and expanding brands. NTR helps to execute its recommendations, assisting in ongoing implementation, working with companies such as Target, Wal-Mart, Hudson’s Bay, Costco, Macy’s, Bloomingdales, BJ’s, Sam’s Club, US Military Exchanges, Tim Hortons and many more. At highest levels, NTR has worked with many major retailers in North America and internationally, including helping bring Walmart to Canada and launching their store-in-store third party businesses.
As Co-Founder/Chief Merchant, Robert worked for John and James Cameron (Avatar) since 2012 for the Human Health Organization and at the same time, following a merger in 2017 with ROKiT Group, owned by John Paul DeJoria (Patron & Paul Mitchell). He was also instrumental in acquisition of MeMD® by Walmart. NTR was also recruited to launch Mode Mobile "The only phone that pays you” and launched it in Walmart and helped grow its subscriber base to 40 million globally. Robert was also key to success during the Pandemic, helping Human Health Org. to “re-launch Hollywood filming”, - from Lionsgate® to Sesame Street® with Covid testing, in addition to disinfectant solutions such as 1st Place Science.
In addition, Robert is Chairman Advisory Board for Twin Towers Trading one of the largest Event based marketing companies of its kind and the largest landlord of Subway in the world, with thousands of QSR locations inside Walmart stores.
Two highlights of Robert’s career include being invited to the White House and guest lecturer at UCLA.